Consolidated Statements of Convertible Preferred Stock, Common Stock and Stockholders’ Equity/(Deficit) - USD ($) $ in Thousands	Class A & B Common Stock	Convertible Preferred Stock	Additional Paid-In Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2020	$ 2	$ 46,670	$ 1,772	$ (31,591)	$ (29,817)
Balance (in Shares) at Dec. 31, 2020	20,662,068	66,550,929
Retroactive application of recapitalization (Note 1)	$ 7	$ (46,670)	46,663		46,670
Retroactive application of recapitalization (Note 1) (in Shares)	66,550,929	(66,550,929)
Adjusted balance, beginning of period	$ 9		48,435	(31,591)	16,853
Adjusted balance, beginning of period (in Shares)	87,212,997
Reverse recapitalization, net of transaction costs (Note 1)	$ 3		97,311		97,314
Reverse recapitalization, net of transaction costs (Note 1) (in Shares)	30,579,972
Cashless exercise of warrants
Cashless exercise of warrants (in Shares)	146,577
Exercise of common stock options			421		421
Exercise of common stock options (in Shares)	1,558,908
Exercise of public warrants			16		16
Exercise of public warrants (in Shares)	1,370
Stock-based compensation			3,694		3,694
Vesting of restricted stock
Vesting of restricted stock (in Shares)	269,243
Net income (loss)				(35,207)	(35,207)
Balance at Dec. 31, 2021	$ 12		149,877	(66,798)	$ 83,091
Balance (in Shares) at Dec. 31, 2021	119,769,067
Cashless exercise of warrants (in Shares)					20
Exercise of common stock options			842		$ 842
Exercise of common stock options (in Shares)	2,291,868
Exercise of public warrants
Exercise of public warrants (in Shares)	20
Stock-based compensation			12,255		12,255
Vesting of restricted stock
Vesting of restricted stock (in Shares)	769,269
Issuance of common stock in an at-the-market offering, net of issuance costs of $300	$ 1		9,699		9,700
Issuance of common stock in an at-the-market offering, net of issuance costs of $300 (in Shares)	3,048,781
Net income (loss)				5,157	5,157
Balance at Dec. 31, 2022	$ 13		$ 172,673	$ (61,641)	$ 111,045
Balance (in Shares) at Dec. 31, 2022	125,879,005